Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros












Intervalo de año de publicación
1.
Reprod Toxicol ; 71: 42-54, 2017 08.
Artículo en Inglés | MEDLINE | ID: mdl-28431985

RESUMEN

HYPOTHESIS: Quercetin could induce changes to the fluid volume and receptivity development of the uterus during peri-implantation period. METHODS: Female rats were treated with quercetin (10, 25 and 50mg/kg/day) subcutaneously beginning from day-1 pregnancy. Uterus was harvested at day-4 (following three days quercetin treatment) for morphological, ultra-structural, protein and mRNA expressional changes and plasma sex-steroid levels analyses. In another cohort of rats, implantation rate was determined at day-6 (following five days quercetin treatment). RESULTS: Administration of 50mg/kg/day quercetin causes increased in uterine fluid volume and CFTR expression but decreased in γ-ENaC, AQP-5, AQP-9 claudin-4, occludin, E-cadherin, integrin αnßЗ, FGF, Ihh and Msx-1expression in the uterus. Pinopodes were poorly develop, tight junctions appear less complex and implantation rate decreased. Serum estradiol levels increased but serum progesterone levels decreased. CONCLUSIONS: Interference in the fluid volume and receptivity development of the uterus during peri-implantation period by quercetin could adversely affect embryo implantation.


Asunto(s)
Implantación del Embrión/efectos de los fármacos , Quercetina/toxicidad , Útero/efectos de los fármacos , Animales , Líquidos Corporales/efectos de los fármacos , Femenino , Proteínas de la Membrana/genética , Proteínas de la Membrana/metabolismo , Microscopía Electrónica de Transmisión , Embarazo , Ratas Sprague-Dawley , Uniones Estrechas/efectos de los fármacos , Uniones Estrechas/ultraestructura , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Útero/metabolismo , Útero/fisiología , Útero/ultraestructura
2.
Braz. J. Pharm. Sci. (Online) ; 53(4): e00054, 2017. tab, graf
Artículo en Inglés | LILACS | ID: biblio-889427

RESUMEN

ABSTRACT This study was carried out to understand the influence of a selected antiarrhythmic drug on the pharmacodynamics and pharmacokinetics of an antidiabetic drug in animal models. Pharmacodynamic and pharmacokinetic responses were determined by measurements of blood glucose and serum insulin and serum metformin to drug interactions between disopyramide and metformin. Single dose and multi dose studies showed that the maximum blood glucose reductions in normal and diabetic rats were at the 6th hour, and in rabbits at the 3rd hour. Glucose-insulin homeostasis was evaluated to assess the safety and effectiveness of the combination. There was a marginal increase in the pharmacokinetic parameters of metformin with multiple dose treatments of disopyramide but no significant changes in kinetic parameters between single and multiple dose studies, compared to metformine alone. There may be a possibility of disopyramide and metformin interaction at the excretion stage, or an additive pharmacodynamic action. This study validates the drug interaction in two dissimilar species, which indicates more probability of its occurrence in humans.


Asunto(s)
Animales , Masculino , Femenino , Conejos , Ratas , Interacciones Farmacológicas , Metformina/farmacocinética , Antiarrítmicos/administración & dosificación , Cromatografía Líquida de Alta Presión/métodos , Diabetes Mellitus/diagnóstico , Disopiramida/farmacocinética , Hipoglucemia
3.
Biomed Pharmacother ; 81: 439-452, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-27261624

RESUMEN

INTRODUCTION: Protective effects of Vitis Vinifera seed aqueous extract (VVSAE) against pancreatic dysfunctions and elevation of oxidative stress, inflammation and apoptosis in the pancreas in diabetes were investigated. Histopathological changes in the pancreas were examined under light microscope. METHODS: Blood and pancreas were collected from adult male diabetic rats receiving 28days treatment with VVSAE orally. Fasting blood glucose (FBG), glycated hemoglobin (HbA1c), insulin and lipid profile levels and activity levels of anti-oxidative enzymes (superoxide dismutase-SOD, catalase-CAT and glutathione peroxidase-GPx) in the pancreas were determined by biochemical assays. Histopathological changes in the pancreas were examined under light microscopy and levels of insulin, glucose transporter (GLUT)-2, tumor necrosis factor (TNF)-α, Ikkß and caspase-3 mRNA and protein were analyzed by real-time PCR (qPCR) and immunohistochemistry respectively. Radical scavenging activity of VVSAE was evaluated by in-vitro anti-oxidant assay while gas chromatography-mass spectrometry (GC-MS) was used to identify the major compounds in the extract. RESULTS: GC-MS analyses indicated the presence of compounds that might exert anti-oxidative, anti-inflammatory and anti-apoptosis effects. Near normal FBG, HbAIc, lipid profile and serum insulin levels with lesser signs of pancreatic destruction were observed following administration of VVSAE to diabetic rats. Higher insulin, GLUT-2, SOD, CAT and GPx levels but lower TNF-α, Ikkß and caspase-3 levels were also observed in the pancreas of VVSAE-treated diabetic rats (p<0.05 compared to non-treated diabetic rats). The extract possesses high in-vitro radical scavenging activities. CONCLUSION: In conclusions, administration of VVSAE to diabetic rats could help to protect the pancreas against oxidative stress, inflammation and apoptosis-induced damage while preserving pancreatic function near normal in diabetes.


Asunto(s)
Apoptosis/efectos de los fármacos , Diabetes Mellitus Experimental/tratamiento farmacológico , Inflamación/tratamiento farmacológico , Estrés Oxidativo/efectos de los fármacos , Páncreas/patología , Extractos Vegetales/uso terapéutico , Sustancias Protectoras/uso terapéutico , Vitis/química , Animales , Antioxidantes/metabolismo , Glucemia/metabolismo , Peso Corporal/efectos de los fármacos , Catalasa/metabolismo , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/genética , Diabetes Mellitus Experimental/patología , Conducta de Ingestión de Líquido/efectos de los fármacos , Ayuno/sangre , Conducta Alimentaria/efectos de los fármacos , Cromatografía de Gases y Espectrometría de Masas , Regulación de la Expresión Génica/efectos de los fármacos , Glutatión Peroxidasa/metabolismo , Hemoglobina Glucada , Inflamación/sangre , Inflamación/patología , Insulina/sangre , Peroxidación de Lípido/efectos de los fármacos , Lípidos/sangre , Masculino , Páncreas/efectos de los fármacos , Extractos Vegetales/farmacología , Sustancias Protectoras/farmacología , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas Wistar , Semillas/química , Superóxido Dismutasa/metabolismo , Agua/química
4.
Int J Med Sci ; 11(11): 1172-84, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25249786

RESUMEN

UNLABELLED: The effect of C. borivilianum root on blood glucose, glycated hemoglobin (HbAIc), insulin and lipid profile levels in diabetes mellitus are not fully understood. This study therefore investigated the effect of C. borivilianum root on the above parameters and oxidative stress of the pancreas in diabetes. METHODS: C. borivilianum root aqueous extract (250 and 500 mg/kg/day) was administered to streptozotocin (STZ)-induced male diabetic rats for 28 days. Body weight, blood glucose, HbA1c, insulin, lipid profile levels and glucose homeostasis indices were determined. Histopathological changes and oxidative stress parameters i.e. lipid peroxidation (LPO) and antioxidant enzymes activity levels of the pancreas were investigated. RESULTS: C. borivilianum root extract treatment to diabetic rats maintained near normal body weight, blood glucose, HbA1c, lipid profile and insulin levels with higher HOMA-ß cell functioning index, number of Islets/pancreas, number of ß-cells/Islets however with lower HOMA-insulin resistance (IR) index as compared to non-treated diabetic rats. Negative correlations between serum insulin and blood glucose, HbA1c, triglyceride (TG) and total cholesterol (TC) levels were observed. C. borivilianum root extract administration prevented the increase in lipid peroxidation and the decrease in activity levels of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) with mild histopathological changes in the pancreas of diabetic rats. CONCLUSIONS: C. borivilianum root maintains near normal levels of these metabolites and prevented oxidative stress-induced damage to the pancreas in diabetes.


Asunto(s)
Glucemia/efectos de los fármacos , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/tratamiento farmacológico , Hipoglucemiantes/uso terapéutico , Insulina/sangre , Liliaceae/química , Lípidos/sangre , Páncreas/efectos de los fármacos , Páncreas/metabolismo , Extractos Vegetales/uso terapéutico , Animales , Hipoglucemiantes/química , Peroxidación de Lípido/efectos de los fármacos , Masculino , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/química , Ratas
5.
BMC Complement Altern Med ; 14: 291, 2014 Aug 08.
Artículo en Inglés | MEDLINE | ID: mdl-25104050

RESUMEN

BACKGROUND: We hypothesized that C. borivilianum root, known to improve male reproductive performance, prevents impairment in characteristics, morphology and elevation of oxidative stress in sperm of diabetics. We therefore investigated the effect of aqueous root extract of C. borivilianum on these parameters in diabetic rat model. METHODS: C. borivilianum root aqueous extract (250 and 500 mg/kg/day) or glibenclamide (600 µg/kg/day) were administered to streptozotocin (STZ)-induced diabetic male rats for 28 consecutive days. At the end of treatment, animals were sacrificed and sperm were collected. Sperm count and percentages of forward motility, viability, hypoosmotic swelling (HOS) tail-coiled and abnormal sperm were evaluated. Sperm lipid peroxidation product (LPO), hydrogen peroxide (H2O2) and nitric oxide (NO) levels, total antioxidant capacity (TAC), activity levels of endogenous antioxidant enzymes (superoxide dismutase-SOD, catalase-CAT and glutathione peroxidase-GPx), epididymal sperm density, serum fasting blood glucose (FBG) and HbA1c levels were measured. The expression of sperm caspase-3 was assessed. Meanwhile, in-vitro free radical scavenging activity of C. borivilianum root extract was determined and the root extract was analyzed for the presence of bioactive compounds by FTIR spectroscopy. RESULTS: C. borivilianum root aqueous extract prevents the decrease in sperm count, percentages of forward motility, viability, HOS and the increase in abnormal sperm percentage and caspase-3 level in diabetic rats. Sperm LPO, H2O2 and NO levels, FBG and HbA1c were lower while TAC, SOD, CAT, GPx and epididymal sperm density were higher in diabetic rats receiving C. borivilianum root extract treatment. C. borivilianum root exhibited strong in-vitro free radical scavenging activity which may be due to the phenolic compound. CONCLUSIONS: C. borivilianum root extract prevents impairment in sperm characteristics and morphology via preventing elevation of oxidative stress, apoptosis and free radicals levels of the sperm in diabetes. These effects may be achieved through maintaining sperm antioxidant level which could be related to free radical scavenging activity of the root extract by phenolic compounds. These effects could also be due to ability of the extract to maintain near normal serum FBG and HBA1c levels in diabetes.


Asunto(s)
Complicaciones de la Diabetes/prevención & control , Infertilidad Masculina/prevención & control , Liliaceae/química , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/administración & dosificación , Espermatozoides/efectos de los fármacos , Animales , Antioxidantes/administración & dosificación , Glucemia/metabolismo , Caspasa 3/metabolismo , Catalasa/metabolismo , Complicaciones de la Diabetes/enzimología , Complicaciones de la Diabetes/etiología , Complicaciones de la Diabetes/metabolismo , Diabetes Mellitus/inducido químicamente , Diabetes Mellitus/metabolismo , Glutatión Peroxidasa/metabolismo , Humanos , Peróxido de Hidrógeno/metabolismo , Infertilidad Masculina/enzimología , Infertilidad Masculina/etiología , Infertilidad Masculina/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Masculino , Raíces de Plantas/química , Ratas , Ratas Wistar , Motilidad Espermática/efectos de los fármacos , Espermatozoides/citología , Espermatozoides/enzimología , Espermatozoides/metabolismo , Estreptozocina , Superóxido Dismutasa/metabolismo
6.
J Renin Angiotensin Aldosterone Syst ; 14(1): 34-40, 2013 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23104304

RESUMEN

INTRODUCTION: The renin-angiotensin system is distributed centrally as well as peripherally, which works in association with SNS and HPA in stress. Angiotensin is considered one of the principal hormones for bringing out stress-related changes. To find the influence of enalapril on the neuromediator of CNS and periphery, the present work was carried out. The assessment of the transmitter levels was done by estimating major urinary stress metabolites like vanillylmandelic acid, 5-hydroxyindoleacetic acid, 6-ß-hydroxycortisol and homovanillic acid in normal and stress-induced conditions and also in the absence and presence of enalapril treatment in rats. MATERIALS AND METHODS: Groups of rats were subjected to a forced swim stress one hour after daily treatment of enalapril. The 24 h urinary excretion of vanillylmandelic acid, 5-hydroxyindoleacetic acid, 6-ß-hydroxycortisol and homovanillic acid was determined in all groups under normal and stressed-induced conditions. RESULTS: Daily administration of enalapril at doses of 3, 10 and 30 mg/kg/body weight inhibited the stress-induced urinary biochemical changes. However, treatment with enalapril in normal conditions increased the excretion of all selected metabolites. CONCLUSION: It can be speculated that enalapril prevented stress-induced increases of adrenergic, serotonergic and cortical mechanisms.


Asunto(s)
Aminas/orina , Enalapril/farmacología , Hidrocortisona/orina , Sistema Renina-Angiotensina/efectos de los fármacos , Estrés Psicológico/orina , Animales , Femenino , Ácido Homovanílico/orina , Hidrocortisona/análogos & derivados , Ácido Hidroxiindolacético/orina , Ratas , Ratas Wistar
7.
Biol Pharm Bull ; 28(4): 729-32, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15802818

RESUMEN

The hypoglycemic and antihyperglycemic effect of alcoholic extract of root of Gmelina asiatica LINN. (G. asiatica) was investigated in normal and in alloxan induced diabetic rats. The blood glucose levels were measured at 0 h and 1, 2, 4, 6, 8 and 16 h after the treatment. The alcoholic extract of G. asiatica showed significant (p<0.05) dose dependent percentage blood glucose reduction in normal (25.8% at 100 mg/kg, 28.9% at 250 mg/kg and 32.4% at 500 mg/kg body weight) and in diabetic rats (26.6% at 100 mg/kg, 32.1% at 250 mg/kg and 48.2% at 500 mg/kg body weight) respectively at 6 h. The antihyperglycemic effect of G. asiatica was compared with the reference standard drug tolbutamide (40 mg/kg).


Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Hipoglucemiantes/farmacología , Lamiaceae/química , Extractos Vegetales/farmacología , Verbenaceae/química , Animales , Glucemia/metabolismo , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas , Femenino , Prueba de Tolerancia a la Glucosa , Hipoglucemiantes/toxicidad , Masculino , Ratones , Nicorandil/farmacología , Extractos Vegetales/toxicidad , Ratas , Ratas Sprague-Dawley , Tolbutamida/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...